# Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3

> **NCT01096095** · PHASE2 · WITHDRAWN · sponsor: **Hospital de Clinicas de Porto Alegre**

## Conditions studied

- Spinocerebellar Ataxia Type 3

## Interventions

- **DRUG:** Placebo
- **DRUG:** Sodium Phenylbutyrate

## Key facts

- **NCT ID:** NCT01096095
- **Lead sponsor:** Hospital de Clinicas de Porto Alegre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-06
- **Primary completion:** 2010-12
- **Final completion:** 2011-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Regulatory authorities did not allow the entrance of the study drug in the country
- **Last updated:** 2012-08-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01096095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01096095, "Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01096095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*